| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ORIGINAL ARTICLES |
From the Departments of Surgical Oncology (CSH, NLW, TH, SBE), Cancer Prevention (HR), Radiation Medicine (WG), and Physical Therapy (KAF), Roswell Park Cancer Institute, Buffalo, New York.
Correspondence: Address correspondence and reprint requests to: Stephen B. Edge, MD, Roswell Park Cancer Institute, Department of Surgical Oncology, Elm and Carlton Streets, Buffalo, NY 14263; Fax: 716-845-1668; E-mail: stephen.edge{at}roswellpark.org
Background: Postmastectomy radiotherapy (PMRT) has proven benefits for certain patients with breast cancer; however, one of its complications is lymphedema. This study examines the incidence of and risk factors associated with lymphedema secondary to PMRT.
Methods: The charts of patients treated with mastectomy at Roswell Park Cancer Institute between January 1, 1995, and April 20, 2001, who received PMRT were reviewed. Univariate analysis of patient, disease, and treatment variables was conducted. Multivariate analysis was performed on variables found to be significant in univariate analysis.
Results: One hundred five patients received PMRT. The incidence of lymphedema was 27%. Patient age, body mass index, disease stage, positive lymph nodes, nodes resected, postoperative infection, duration of drainage, chemotherapy, and hormonal therapy were not associated with lymphedema. Total dose (P = .032), posterior axillary boost (P = .047), overlap technique (P = .037), radiotherapy before 1999 (P = .028), and radiotherapy at Roswell Park Cancer Institute (P = .028) were significantly associated with lymphedema. Increased lymphedema was noted with supraclavicular, internal mammary, mastectomy scar boost, and chest wall tangential photon beam radiation, but the associations were not statistically significant.
Conclusions: The high incidence and debilitating effects of lymphedema must be weighed against the benefits of PMRT. Efforts to prevent lymphedema should be emphasized.
Key Words: Lymphedema • Postmastectomy radiation • Risk factors • Complications • Breast neoplasms
This article has been cited by other articles:
 |
|
 |
|
  Y.-C. T. Shih, Y. Xu, J. N. Cormier, S. Giordano, S. H. Ridner, T. A. Buchholz, G. H. Perkins, and L. S. Elting Incidence, Treatment Costs, and Complications of Lymphedema After Breast Cancer Among Women of Working Age: A 2-Year Follow-Up Study J. Clin. Oncol., April 20, 2009; 27(12): 2007 - 2014. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. D. Lawenda, T. E. Mondry, and P. A. S. Johnstone Lymphedema: A primer on the identification and management of a chronic condition in oncologic treatment CA Cancer J Clin, January 1, 2009; 59(1): 8 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. W. Clavin, T. Avraham, J. Fernandez, S. V. Daluvoy, M. A. Soares, A. Chaudhry, and B. J. Mehrara TGF-{beta}1 is a negative regulator of lymphatic regeneration during wound repair Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H2113 - H2127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. N. Lane, L. B. Dolan, D. Worsley, and D. C. McKenzie Upper extremity lymphatic function at rest and during exercise in breast cancer survivors with and without lymphedema compared with healthy controls J Appl Physiol, September 1, 2007; 103(3): 917 - 925. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. D. Paskett, M. J. Naughton, T. P. McCoy, L. D. Case, and J. M. Abbott The Epidemiology of Arm and Hand Swelling in Premenopausal Breast Cancer Survivors Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 775 - 782. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Korosec Manual Lymphatic Drainage Therapy Home Health Care Management Practice, October 1, 2004; 16(6): 499 - 511. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
